FDA approves Xanodyne's Lysteda for heavy menstrual bleeding
This article was originally published in Scrip
Executive Summary
The US FDA has approved Xanodyne's Lysteda tablets (tranexamic acid; XP-12B) as the first non-hormonal product to treat heavy menstrual bleeding (menorrhagia).